Barclays Plc stock price, TAPR

Barclays Plc stock chart:



Barclays Plc close price: 25.61

Stock price forecast:

DOWN TO -0.08%
Target: 25.59

Total forecasts: 82
Reached: 44 (53.66%)

Total Win: 29.19 (116.53%)

DaysForecastsReached%Reached points%InvestedUnreached%Total%
No results found.

Showing 1-10 of 572 items.
Date of ForecastStock PriceTarget PriceForecast Reached Date
2017-05-2925.6125.590000-00-00
2017-05-2825.6125.50000-00-00
2017-05-2725.6125.520000-00-00
2017-05-2625.6125.520000-00-00
2017-05-2525.6125.360000-00-00
2017-05-2425.6126.040000-00-00
2017-05-2325.6126.270000-00-00
2017-05-2225.6126.090000-00-00
2017-05-2125.6126.230000-00-00
2017-05-2025.6126.330000-00-00

Barclays Plc latest news:


  • 05/25/2017 12:00:19

    Appain shares soaring in company's debut on the Nasdaq

    Shares of Appian Corp. were soaring 36% midday Thursday after the software company's debut on the Nasdaq. Appian, which provides a software development platform for organizations, sold 6.25 million shares at $12 each to raise $75 million. Appian recorded revenue of $132.9 million in 2016, up from $111.2 million in 2015 on top of net losses of $12.5 million in 2016, wider than a net loss of $7 million in 2015. Appian has granted its underwriters a 30-day option to buy an additional 937,400 shares of common stock. Morgan Stanley, Goldman Sachs & Co and Barclays were the lead underwriters on the offering. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 05/12/2017 09:01:21

    Wynn Resorts stock jumps 3.3% to lead S&P 500 gainers after Barclays upgrade

    Wynn Resorts Ltd. shares climbed 3.3% Friday to lead S&P 500 gainers, after Barclays upgraded the stock to the equivalent of buy, citing positive news coming from Macau and Las Vegas. Barclays upgraded the stock to overweight from equal weight and raised its price to $144, equal to 13% upside from current levels. Wynn Resorts beat profit estimates by about 30% in its latest quarter, and beat sales estimates by 5.5%, according to FactSet. Revenue from its Las Vegas operations rose 6% from the year-earlier period, while casino revenues were up 3.3%. In Macau, net revenues fell 3.5%, while casino revenues were down 3%. But Macau is expected to continue a recovery that began last August with the opening of Wynn's new Palace casino, which is credited with bringing VIP high-rollers back. Macau has posted nine straight months of higher gambling revenues, according to the Macau Gaming Inspection & Coordination Bureau. Wynn shares have gained 46% in 2017, while the S&P 500 has gained 7%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 05/11/2017 09:43:29

    Exclusive: Barclays rejigs global investment banking team, seeks new hires

    LONDON (Reuters) - Barclays reshuffled its senior global investment bank management on Thursday and is seeking to hire between 50 to 100 people to boost the division under new chief Tim Throsby, according to sources with direct knowledge of the plans.

  • 05/10/2017 13:50:51

    SEC: Barclays to pay $97 million for overcharging clients

    Barclays will pay $97 million to settle charges that it overcharged its clients millions of dollars in fees due to billing errors, miscalculations and for recommending expensive investments

  • 05/10/2017 10:12:18

    Barclays to pay $97 million to settle charges it overcharged clients

    WASHINGTON (Reuters) - Barclays will pay more than $97 million to settle civil charges, after U.S. regulators said Wednesday the company overcharged clients from its asset management business by millions of dollars.

  • 05/10/2017 09:49:50

    Barclays boss sees off shareholder rebellion

    Jes Staley is re-elected to Barclays board despite threats of a backlash over whistleblowing scandal.

  • 05/10/2017 05:30:00

    Barclays boss apologises to shareholders

    Jes Staley says he regrets whistleblowing scandal ahead of a vote on his re-election to the board.

  • 05/10/2017 02:22:25

    Barclays boss set for shareholder grilling at AGM

    Investors will vote on whether to re-elect Jes Staley to the bank's board, amid controversy over whistleblowing claims.

  • 05/04/2017 06:56:08

    Biohaven Pharmaceutical raises $168 million in initial public offering

    Biohaven Pharmaceutical Holding Company priced its initial public offering at $17 a share Thursday to raise $168.3 million. The company sold 9.9 million shares and has granted underwriters a 30-day option to buy an additional 1.485 million shares. The shares are expected to start trading Thursday under the symbol "BHVN." Morgan Stanley, Piper Jaffray & Co and Barclays Capital are the joint book-running managers on the offering. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 05/02/2017 11:09:46

    Barclays CEO Staley in dispute with KKR over soured deal: WSJ

    LONDON (Reuters) - Barclays Chief Executive Jes Staley is involved in a dispute with private equity firm KKR & Co , which is a client of the bank, the Wall Street Journal reported on Tuesday.

  • 05/02/2017 11:02:36

    Barclays CEO Staley in dispute with KKR over soured deal - WSJ

    LONDON, May 2 (Reuters) - Barclays Chief Executive Jes Staley is involved in a dispute with private equity firm KKR & Co, which is a client of the bank, the Wall Street Journal reported on Tuesday.

  • 05/01/2017 17:56:47

    BRIEF-Rambus initiates accelerated share repurchase program

    * Rambus - initiated accelerated share repurchase program with Barclays to repurchase about $50 million of common stock, with initial delivery of 3.2 million shares Source text for Eikon: Further company coverage:

  • 04/28/2017 00:19:00

    Barclays profit more than doubles to £1.68bn

    Barrclays has seen its profit before tax more than double in the first three months of 2017 compared to the same period last year.

  • 04/28/2017 00:13:43

    Barclays profits more than double

    The bank reports a big rise in profits for the first quarter, boosted by a healthier core business.

  • 04/26/2017 08:39:56

    Barclays boss sounds Brexit talent warning

    Jes Staley says that retaining access to talented workers after Brexit is "tremendously important".

  • 04/23/2017 13:49:00

    Jones to be named as new voice of UK banking

    A former Barclays and Santander executive will be unveiled as the new voice of the UK banking sector on Monday with a mandate to rebuild trust in the still-embattled industry.

  • 04/10/2017 10:42:44

    Barclays chief Staley censured for bid to identify whistleblower

    Bank’s head faces ‘very significant’ pay cut as punishment amid FCA and BoE inquiry

  • 04/10/2017 09:26:37

    Barclays reprimands chief executive for trying to identify whistleblower

    LONDON (Reuters) - British bank Barclays has reprimanded Chief Executive Jes Staley and will cut his bonus heavily after he tried to uncover the identity of an internal company whistleblower in a case being investigated on both sides of the Atlantic.

  • 04/10/2017 01:54:07

    Regulators investigate Barclays CEO Staley over whistleblowing case

    LONDON (Reuters) - British regulators are investigating Barclays Chief Executive Jes Staley and the bank itself over the handling of a whistleblowing incident, the bank said on Monday.

  • 04/10/2017 01:05:37

    City regulators investigate Barclays boss Jes Staley

    Jes Staley's conduct over a whistleblowing letter will be investigated by two financial regulators.

  • 04/10/2017 00:43:33

    Barclays CEO Staley under investigation by regulators; bank to dock bonus

    Barclays PLC has reprimanded its chief executive, Jes Staley, and will dock his bonus after he broke rules by attempting to identify a whistleblower, the bank said Monday. U.K. regulators the Financial Conduct Authority and the Prudential Regulation Authority are investigating Barclays and Staley over their responsibilities in the incident, the bank said in a statement. In June 2016, Staley asked the Barclays's information security team to try to identify the anonymous sender of a letter that raised concerns about a senior bank employee, which Staley regarded as an unfair attack, an investigation by the bank found. "The Board believes that its response to the matter should be proportionate to its serious nature. It will therefore be issuing a formal written reprimand to Mr. Staley and has decided that a very significant compensation adjustment will be made to Mr. Staley's variable compensation award," Barclays said in its statement. It will determine the amount of the adjustment once the FCA and PRA have ended their investigations.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 04/07/2017 15:33:35

    Neurological drug developer Biohaven files for initial public offering

    Biohaven Pharmaceutical Holding Co. is looking to raise up to $100 million in an initial public offering, according to a Securities and Exchange Commission filing late Friday. The biotech drug developer specializes in drugs for neurological diseases with product candidate rimegepant expected to begin late-stage clinical trials for the treatment of migraines in the second half of 2017. Biohaven also expects early 2018 clinical-trial results for its drug trigriluzole for the treatment of ataxia, a condition where sufferers lose control of voluntary body movements. With no revenue, Biohaven reported a loss of $63.7 million, or $5.05 a share, in 2016. Morgan Stanley, Piper Jaffray, and Barclays are listed among the underwriters. The company plans to list on the New York Stock Exchange under the ticker "BHVN". Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 04/06/2017 05:40:25

    Two Barclays traders found not guilty in Libor retrial

    In a second trial, Ryan Reich and Stylianos Contogoulas are acquitted of conspiring to defraud.

  • 04/03/2017 11:59:49

    Canadian biopharma company Zymeworks files for U.S. IPO

    Canadian biopharmaceutical company Zymeworks said it has filed with the U.S. Securities and Exchange Commission for an initial public offering. The company, which develops cancer treatments, said it intends to list on the New York Stock Exchange and the Toronto Stock Exchange under the ticker symbol "ZYME". Citigroup, Barclays and Wells Fargo are joint book runners with Cannacord Genuity acting as lead manager and Cormark Securities acting as co-manager. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 04/03/2017 05:11:29

    Canadian biopharma company Zymeworks files with for U.S. IPO

    Canadian biopharmaceutical company Zymeworks said it has filed with the U.S. Securities and Exchange Commission for an initial public offering. The company, which develops cancer treatments, said it intends to list on the New York Stock Exchange and the Toronto Stock Exchange under the ticker symbol "ZYME". Citigroup, Barclays and Wells Fargo are joint book runners with Cannacord Genuity acting as lead manager and Cormark Securities acting as co-manager. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 03/17/2017 01:45:59

    Bob Diamond in deal to buy stockbroker Panmure Gordon

    The former Barclays boss joins forces with the Qatari royal family to take control of the broker.

  • 03/17/2017 01:34:43

    Diamond joins Qataris to launch Panmure Gordon bid

    Barclays ex-chief makes City return with move for lossmaking broker

  • More trends:

    Barington/Hilco Acquisition Corp.BHAC | Barington/Hilco Acquisition Corp.BHACR | Barington/Hilco Acquisition Corp.BHACU | Barington/Hilco Acquisition Corp.BHACW | Barrett Business Services, Inc.BBSI | Bassett Furniture Industries, IncorporatedBSET | Bay Bancorp, Inc.BYBK | Baylake CorpBYLK | Bazaarvoice, Inc.BV | BBCN Bancorp, Inc.BBCN |